Catalyst Wire Dossier Catalyst Wire Dossier

BAY 1895344

BAY 1895344 · Bayer AG
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for BAY 1895344, covering 2024-10-10 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer [Phase 1]

See pricing